VAERS ID: 2265772

Description

Very Bad Nose Bleeds; Elevated BP/my BP spiked to 140/98; Elevated heart rate/ my heartrate accelerated to over 100 bpm; Throat Tightened; Chest tightened; Difficult to breath; Severe Headache; Mild Pain/ Mild body aches; Anaphylaxis; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 55-year-old female patient received BNT162b2 (COMIRNATY), on 22Mar2022 at 10:30 as dose 2, single (Lot number: PCA0033) at the age of 55 years for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: FLU VACCINE VII taken for immunisation. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for Covid-19 Immunization. The following information was reported: ANAPHYLACTIC REACTION (medically significant) with onset 22Mar2022 at 12:30, outcome "recovering", described as "Anaphylaxis"; CHEST DISCOMFORT (non-serious) with onset 22Mar2022 at 12:30, outcome "recovering", described as "Chest tightened"; DYSPNOEA (non-serious) with onset 22Mar2022 at 12:30, outcome "recovering", described as "Difficult to breath"; BLOOD PRESSURE INCREASED (non-serious) with onset 22Mar2022 at 12:30, outcome "recovering", described as "Elevated BP/my BP spiked to 140/98"; HEART RATE INCREASED (non-serious) with onset 22Mar2022 at 12:30, outcome "recovering", described as "Elevated heart rate/ my heartrate accelerated to over 100 bpm"; PAIN (non-serious) with onset 22Mar2022 at 12:30, outcome "recovering", described as "Mild Pain/ Mild body aches"; HEADACHE (non-serious) with onset 22Mar2022 at 12:30, outcome "recovering", described as "Severe Headache"; THROAT TIGHTNESS (non-serious) with onset 22Mar2022 at 12:30, outcome "recovering", described as "Throat Tightened"; EPISTAXIS (medically significant) with onset 24Mar2022, outcome "recovering", described as "Very Bad Nose Bleeds". The patient underwent the following laboratory tests and procedures: Blood pressure measurement: (22Mar2022) 140/98, notes: (no units given); Heart rate: (22Mar2022) 100 bpm, notes: over 100 bpm. Therapeutic measures were taken as a result of epistaxis. No follow-up attempts are possible. No further information is expected. Follow-up (03May2022): This is a follow-up spontaneous report received from the contactable reporter(s) (Consumer or other non HCP). Updated information: Concomitant medication, Outcomes of the events were updated as "recovering/resolving". Treatment for nose bleeding included nose cauterization and was upgraded to medically significant. The patient was not hospitalized. The patient did not have a history of any previous allergies to specific products or any conditions indicative of an allergy. No follow-up attempts are possible. No further information is expected.